(ZEROHEDGE) – Psychedelic drugs have been a hot topic in the financial press this week. Between the hallucinatory experiences of a German billionaire, and the market debut of 'magic mushroom' company MindMed eliciting talk of a "shroom boom", most of that coverage has been refreshingly positive. But that changed Tuesday morning when Bloomberg reported that the CEO of a $2 billion startup has been unceremoniously fired for "microdosing" with LSD at work.
The board of Marketing startup Iterable dismissed the CEO, Justin Zhu, for taking LSD before a meeting back in 2019. Zhu told Bloomberg he had "experimented" by taking a small amount of the drug (a practice known as "microdosing") in an attempt to boost his focus. Looking back, he probably should have kept this information to himself.
Because in an email to staff, co-founder Andrew Boni said Zhu’s dismissal was over unspecified violations of "Iterable’s Employee Handbook, policies and values."
The post CEO of $2 billion startup fired for 'microdosing' on LSD at work appeared first on WND.
